What are the major opportunities in the cancer biomarker market? What are the strategies for the cancer biomarker market?

For detailed insights on the major opportunities and strategies in the cancer biomarker market, Read More

How does the cancer biomarker market relate to the overall economy and other similar markets?

For detailed insights on cancer biomarker market's relation to the overall economy and other similar markets, Read More

What are the latest mergers and acquisitions in the cancer biomarker industry?

For detailed insights on the mergers and acquisitions in the cancer biomarker industry, Read More

What are the key dynamics influencing the cancer biomarker market growth? SWOT analysis of the cancer biomarker market.

For detailed insights on the key dynamics influencing the cancer biomarker market growth and SWOT analysis of the cancer biomarker industry, Read More

Global Cancer Biomarker Market Report 2025

Report Price : $4490.00

Pages : 200

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report

Cancer Biomarker Global Market Report 2025

Name: Cancer Biomarker Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Biomarkers Type (Protein Biomarkers, Genetic Biomarkers, Other Cancer Biomarkers), By Profiling Technologies (Omics Technologies, Imaging Technologies, Immunoassay, Bioinformatics, Cytogenetics), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Thyroid Cancer, Kidney Cancer, Other Cancers), By Application (Diagnostics, Research And Development, Prognostics, Risk Assessment, Other Applications) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Cancer Biomarker Market Overview

• Cancer Biomarker market size has reached to $22.19 billion in 2024

• Expected to grow to $45.33 billion in 2029 at a compound annual growth rate (CAGR) of 15.9%

• Growth Driver: The Surging Incidence Of Cancer Fueling Growth In The Cancer Biomarker Market

• Market Trend: Advancements In AI-Powered Cancer Biomarkers: Enhancing Diagnosis And Treatment Precision

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cancer Biomarker Market?

A cancer biomarker refers to a biological molecule present in the blood, tissues, or other bodily fluids, that indicates the presence of normal or abnormal activity, as well as a condition or disease. Cancer biomarkers are used to characterize alterations in the tumor.

The main types of cancer biomarker are protein biomarkers, genetic biomarkers, and other that uses omics technologies, imaging technologies, immunoassay, bioinformatics-global-market-report" target="_blank">bioinformatics-global-market-report" target="_blank">bioinformatics, and cytogenetics profiling technologies. Protein biomarkers refer to detectable flags in a patient's blood that corresponds with significant events or signal distinct states in a biological process, such as disease progression. Protein biomarkers are used to perform accurate disease diagnosis. The cancer biomarker is used in various cancer such as breast cancer, lung cancer, colorectal cancer, prostate cancer, thyroid cancer, kidney cancer, and other cancers. It is used in diagnostics, research and development, prognostics, risk assessment, and other applications.

Cancer Biomarker Market Size and growth rate 2025 to 2029: Graph

What Is The Cancer Biomarker Market Size 2025 And Growth Rate?

What Is The Cancer Biomarker Market Growth Forecast?

The cancer biomarker market size is expected to see rapid growth in the next few years. It will grow to $45.33 billion in 2029 at a compound annual growth rate (CAGR) of 15.9%. The growth in the forecast period can be attributed to shift to patient-centric diagnostics, integration of biomarkers in clinical trials, emergence of multiplex biomarker panels, exploration of non-coding RNAs, commercialization of biomarker tests. Major trends in the forecast period include advancements in genomics, precision medicine approaches, liquid biopsies, immunotherapy advancements, artificial intelligence (ai) integration.

The forecast of 15.9% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on monoclonal antibody conjugates and multiplex immunoassay reagents, sourced from key regions such as Denmark and Japan, which could lead to delayed cancer detection and higher costs for precision medicine diagnostics.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Medical Equipment Industry?

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

How Is The Cancer Biomarker Market Segmented?

1) By Biomarkers Type: Protein Biomarkers, Genetic Biomarkers, Other Cancer Biomarkers

2) By Profiling Technologies: Omics Technologies, Imaging Technologies, Immunoassay, Bioinformatics, Cytogenetics

3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Thyroid Cancer, Kidney Cancer, Other Cancers

4) By Application: Diagnostics, Research And Development, Prognostics, Risk Assessment, Other Applications

Subsegments:

1) By Protein Biomarkers: Tumor-Specific Antigens, Circulating Tumor Protein

2) By Genetic Biomarkers: DNA Mutations, RNA Expression Profiles

3) By Other Cancer Biomarkers: Epigenetic Biomarkers, Metabolomic Biomarkers

What Is Driving The Cancer Biomarker Market? The Surging Incidence Of Cancer Fueling Growth In The Cancer Biomarker Market

The rising incidence of cancer is driving the growth of the cancer biomarker market. The cancer incidence rate is the number of new cancers of a specific site/type that occur in a given population during a given year, represented as cancers per 100,000 people at risk. The increasing incidence of cancer is leading to the widespread use of cancer biomarkers because it helps in assessing disease risk, screening for occult primary tumors, identifying benign from malignant signs, or separating one form of malignancy from another. For instance, in January 2022, according to research published by the American Cancer Society, a US-based health organization, in the US, 609,360 cancer deaths and 1.9 million new cancer cases are anticipated in 2022. It is about 1,670 fatalities each day. Therefore, the rising incidence of cancer packaging is expected to propel the growth of the cancer biomarker industry in the coming years.

What Is Driving The Cancer Biomarker Market? Growing Geriatric Population Fuels Cancer Biomarker Market Expansion

The increase in the geriatric population is expected to boost the growth of the cancer biomarker market going forward. The geriatric population refers to the percentage of people 65 and older to those between the ages of 18 and 64 who are employed. The aging population is at an increased risk of developing cancer, thereby it amplifies the demand for cancer biomarkers by emphasizing the need for early detection, personalized treatment, and targeted interventions. For instance, in October 2022, according to a report published by the World Health Organization (WHO), a Switzerland-based agency responsible for international public health, one in six people is expected to be 60 or older by the year 2030, in the entire world. In the year 2050, the global population of individuals aged 60 years and older is projected to reach 2.1 billion. Therefore, the increase in the geriatric population is driving the growth of the cancer biomarker industry.

Who Are The Major Players In The Global Cancer Biomarker Market?

Major companies operating in the cancer biomarker market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., QIAGEN NV, Illumina Inc., Bio-Rad Laboratories Inc., Abbott Laboratories, bioMérieux SA, Becton Dickinson and Company, Merck & Co. Inc., Bristol-Myers Squibb Company, PerkinElmer Inc., Siemens AG, Exact Sciences Corporation, Novartis AG, Agilent Technologies Inc., Hologic Inc., Myriad Genetics Inc., Foundation Medicine Inc., Guardant Health Inc., Natera Inc., Sysmex Corporation, Biocartis Group NV, NanoString Technologies Inc., Veracyte Inc., Epic Sciences Inc., Cynvenio Biosystems Inc., Genomic Health Inc., Oncocyte Corporation, Exosome Diagnostics Inc., Grail Inc.

What Are The Key Trends Of The Global Cancer Biomarker Market? Advancements In AI-Powered Cancer Biomarkers: Enhancing Diagnosis And Treatment Precision

Major companies operating in the cancer biomarker market are focusing on developing innovative solutions, such as AI-powered cancer biomarkers, to enhance diagnostic accuracy and personalize treatment plans for patients. AI-powered cancer biomarkers refer to biological indicators of cancer that are identified and analyzed using artificial intelligence technologies. For instance, in September 2023, Ibex Medical Analytics, a US-based Ibex Medical Analytics, launched Galen Breast HER2, an AI-powered solution designed to enhance the accuracy and reproducibility of HER2 scoring in breast cancer patients. This innovative platform aids pathologists by automatically detecting invasive tumor areas and quantifying HER2 expression based on the 2018 ASCO/CAP guidelines. The Galen Breast HER2 system utilizes a novel computational pipeline to analyze immunohistochemistry (IHC)-stained slides, providing detailed visualizations of staining patterns and enabling pathologists to make informed treatment decisions.

What Are The Key Trends Of The Global Cancer Biomarker Market? Pioneering Advancements In Cancer Biomarkers Market

Major companies operating in the cancer biomarker market are developing innovative products such as AI-powered cancer diagnostics solutions to meet larger customer bases, more sales, and increase revenue. An AI-powered cancer diagnostics solution refers to a technological system that utilizes artificial intelligence (AI) algorithms, including techniques such as machine learning, deep learning, and other advanced computational methods, to analyze medical data and assist in the detection, diagnosis, and characterization of cancer. For instance, in September 2023, Ibex Medical Analytics, an Israel-based medical technology manufacturer, launched Galen Breast HER2 to assist in the evaluation of biomarker scores for breast cancer. This unique solution aids in patient selection for targeted therapies, employing an innovative AI-powered computational pipeline to analyze HER2 IHC-stained slides. It automatically detects invasive tumor areas, identifies tumor cells, discerns their staining patterns, and swiftly calculates the HER2 IHC score with exceptional accuracy and reproducibility. It supports pathologists in establishing a heightened benchmark for precise and consistent scoring of HER2 (human epidermal growth factor receptor 2) in breast cancer patients. Ibex's Galen Breast HER2, an AI-powered solution for HER2 IHC (immunohistochemistry) scoring, identifies invasive tumor regions and categorizes HER2 expression into four standard classifications (0, 1+, 2+, and 3+) according to the 2018 ASCO/CAP scoring guidelines.

Need data on a specific region in this market?

Request Customisation

Cancer Biomarker Market Merger And Acquisition: Biocare Medical Acquires Empire Genomics To Enhance Cancer Diagnostics Capabilities

In November 2022, Biocare Medical, a California-based company specializing in the development and supply of automated immunohistochemistry (IHC), acquired Empire Genomics for an undisclosed amount. The aim of this acquisition is to enhance Biocare Medical's capabilities in cancer diagnostics by integrating a comprehensive suite of molecular biomarkers and custom genomic development solutions. Empire Genomics is a U.S.-based biotechnology company that develops and sells molecular diagnostics and genomic products, including cancer biomarkes.

Regional Outlook For The Global Cancer Biomarker Market

North America was the largest region in the cancer biomaker market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cancer Biomarker Market?

The cancer biomarker market consists of sales of epigenetic biomarkers, and metabolic biomarkers for various cancers such as melanoma, leukemia, bladder cancer, non-hodgkin's lymphoma, endometrial cancer, pancreatic cancer, and liver cancer. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Cancer Biomarker Industry?

The cancer biomarker market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cancer biomarker industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Cancer Biomarker Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$25.09 billion
Revenue Forecast In 2034	$45.33 billion
Growth Rate	CAGR of 15.9% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Biomarkers Type: Protein Biomarkers, Genetic Biomarkers, Other Cancer Biomarkers 2) By Profiling Technologies: Omics Technologies, Imaging Technologies, Immunoassay, Bioinformatics, Cytogenetics 3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Thyroid Cancer, Kidney Cancer, Other Cancers 4) By Application: Diagnostics, Research And Development, Prognostics, Risk Assessment, Other Applications Subsegments: 1) By Protein Biomarkers: Tumor-Specific Antigens, Circulating Tumor Protein 2) By Genetic Biomarkers: DNA Mutations, RNA Expression Profiles 3) By Other Cancer Biomarkers: Epigenetic Biomarkers, Metabolomic Biomarkers
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., QIAGEN NV, Illumina Inc., Bio-Rad Laboratories Inc., Abbott Laboratories, bioMérieux SA, Becton Dickinson and Company, Merck & Co. Inc., Bristol-Myers Squibb Company, PerkinElmer Inc., Siemens AG, Exact Sciences Corporation, Novartis AG, Agilent Technologies Inc., Hologic Inc., Myriad Genetics Inc., Foundation Medicine Inc., Guardant Health Inc., Natera Inc., Sysmex Corporation, Biocartis Group NV, NanoString Technologies Inc., Veracyte Inc., Epic Sciences Inc., Cynvenio Biosystems Inc., Genomic Health Inc., Oncocyte Corporation, Exosome Diagnostics Inc., Grail Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Cancer Biomarker Market Characteristics

3. Cancer Biomarker Market Trends And Strategies

4. Cancer Biomarker Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cancer Biomarker Growth Analysis And Strategic Analysis Framework

5.1. Global Cancer Biomarker PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Cancer Biomarker Market Growth Rate Analysis

5.4. Global Cancer Biomarker Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Cancer Biomarker Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Cancer Biomarker Total Addressable Market (TAM)

6. Cancer Biomarker Market Segmentation

6.1. Global Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Protein Biomarkers

Genetic Biomarkers

Other Cancer Biomarkers

6.2. Global Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Omics Technologies

Imaging Technologies

Immunoassay

Bioinformatics

Cytogenetics

6.3. Global Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Breast Cancer

Lung Cancer

Colorectal Cancer

Prostate Cancer

Thyroid Cancer

Kidney Cancer

Other Cancers

6.4. Global Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Diagnostics

Research And Development

Prognostics

Risk Assessment

Other Applications

6.5. Global Cancer Biomarker Market, Sub-Segmentation Of Protein Biomarkers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tumor-Specific Antigens

Circulating Tumor Protein

6.6. Global Cancer Biomarker Market, Sub-Segmentation Of Genetic Biomarkers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

DNA Mutations

RNA Expression Profiles

6.7. Global Cancer Biomarker Market, Sub-Segmentation Of Other Cancer Biomarkers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Epigenetic Biomarkers

Metabolomic Biomarkers

7. Cancer Biomarker Market Regional And Country Analysis

7.1. Global Cancer Biomarker Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Cancer Biomarker Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cancer Biomarker Market

8.1. Asia-Pacific Cancer Biomarker Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cancer Biomarker Market

9.1. China Cancer Biomarker Market Overview

9.2. China Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cancer Biomarker Market

10.1. India Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cancer Biomarker Market

11.1. Japan Cancer Biomarker Market Overview

11.2. Japan Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cancer Biomarker Market

12.1. Australia Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cancer Biomarker Market

13.1. Indonesia Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cancer Biomarker Market

14.1. South Korea Cancer Biomarker Market Overview

14.2. South Korea Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cancer Biomarker Market

15.1. Western Europe Cancer Biomarker Market Overview

15.2. Western Europe Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cancer Biomarker Market

16.1. UK Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cancer Biomarker Market

17.1. Germany Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cancer Biomarker Market

18.1. France Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cancer Biomarker Market

19.1. Italy Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cancer Biomarker Market

20.1. Spain Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cancer Biomarker Market

21.1. Eastern Europe Cancer Biomarker Market Overview

21.2. Eastern Europe Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cancer Biomarker Market

22.1. Russia Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cancer Biomarker Market

23.1. North America Cancer Biomarker Market Overview

23.2. North America Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cancer Biomarker Market

24.1. USA Cancer Biomarker Market Overview

24.2. USA Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cancer Biomarker Market

25.1. Canada Cancer Biomarker Market Overview

25.2. Canada Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cancer Biomarker Market

26.1. South America Cancer Biomarker Market Overview

26.2. South America Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cancer Biomarker Market

27.1. Brazil Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cancer Biomarker Market

28.1. Middle East Cancer Biomarker Market Overview

28.2. Middle East Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cancer Biomarker Market

29.1. Africa Cancer Biomarker Market Overview

29.2. Africa Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cancer Biomarker Market Competitive Landscape And Company Profiles

30.1. Cancer Biomarker Market Competitive Landscape

30.2. Cancer Biomarker Market Company Profiles

30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. QIAGEN NV Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Cancer Biomarker Market Other Major And Innovative Companies

31.1. Abbott Laboratories

31.2. bioMérieux SA

31.3. Becton Dickinson and Company

31.4. Merck & Co. Inc.

31.5. Bristol-Myers Squibb Company

31.6. PerkinElmer Inc.

31.7. Siemens AG

31.8. Exact Sciences Corporation

31.9. Novartis AG

31.10. Agilent Technologies Inc.

31.11. Hologic Inc.

31.12. Myriad Genetics Inc.

31.13. Foundation Medicine Inc.

31.14. Guardant Health Inc.

31.15. Natera Inc.

32. Global Cancer Biomarker Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cancer Biomarker Market

34. Recent Developments In The Cancer Biomarker Market

35. Cancer Biomarker Market High Potential Countries, Segments and Strategies

35.1 Cancer Biomarker Market In 2029 - Countries Offering Most New Opportunities

35.2 Cancer Biomarker Market In 2029 - Segments Offering Most New Opportunities

35.3 Cancer Biomarker Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Cancer Biomarker Market, Sub-Segmentation Of Protein Biomarkers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Cancer Biomarker Market, Sub-Segmentation Of Genetic Biomarkers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Cancer Biomarker Market, Sub-Segmentation Of Other Cancer Biomarkers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Cancer Biomarker Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Cancer Biomarker Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: F. Hoffmann-La Roche AG Financial Performance

Table 79: Thermo Fisher Scientific Inc. Financial Performance

Table 80: QIAGEN NV Financial Performance

Table 81: Illumina Inc. Financial Performance

Table 82: Bio-Rad Laboratories Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Cancer Biomarker Market, Sub-Segmentation Of Protein Biomarkers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Cancer Biomarker Market, Sub-Segmentation Of Genetic Biomarkers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Cancer Biomarker Market, Sub-Segmentation Of Other Cancer Biomarkers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Cancer Biomarker Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Cancer Biomarker Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: F. Hoffmann-La Roche AG Financial Performance

Figure 79: Thermo Fisher Scientific Inc. Financial Performance

Figure 80: QIAGEN NV Financial Performance

Figure 81: Illumina Inc. Financial Performance

Figure 82: Bio-Rad Laboratories Inc. Financial Performance

Major Drivers Propelling the Growth oh theIntravenous Stopcock Market Forward: Rising Demand For Accurate Fluid Control Devices Fueling The Growth Of The Market Due To Enhanced Medication Precision And Patient Safety

Major Trends and Emerging Patterns in the Personal Emergency Response Systems (PERS) Market: Advanced Medical Alert Devices Enhancing Emergency Response And Healthcare Management

Key Factors Fueling the Growth of the Physiotherapy Equipment Market in 2025: Rising Osteoporosis Cases Driving The Growth Of The Market Due To Increasing Aging Population And Sedentary Lifestyles

Critical Market Drivers Shaping the Outlook for Positive Air Pressure Devices Market from 2025-2034: Rising Prevalence Of Respiratory Disorders Fueling The Growth Of The Market Due To Increasing Demand For Effective Breathing Solutions

The global medical gloves market report offers strategic insights and market intelligence through 2025.

Explore future investment planning strategies in the global medical needle-free injection market through 2025.

Strategic growth analysis and competitive advantage in the global topoisomerase I inhibitors market.

Explore business opportunities, growth strategies, and trends in the total ankle replacement market through 2034.

Pain Management Devices And Therapies Global Market Report 2025 – By Type (Electrical Stimulators, Ablation Devices, Neurostimulators, Analgesic Pumps), By Neurostimulation Devices (Spinal Cord Stimulation (SCS) Devices,...

View Report

Metabolomics Global Market Report 2025 – By Product & Service (Metabolomics Instruments, Metabolomics Bioinformatics Tools & Services), By Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Erro...

View Report

Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2025 – By Product (Instrument, Reagent), By Technology (NASBA, HAD), By Application (Blood Screening, Infectious Disease Diagnostics, Cancer),...

View Report

Monoclonal Antibodies (MAs) Global Market Report 2025 – By Source (Murine, Chimeric, Humanized, Human), By Application (Anti-Cancer, Immunological, Anti-Infective Monoclonal Antibodies (MAs), Neuropharmacological, Cardio...

View Report

Cancer biologics Global Market Report 2025 – By Type (Monoclonal Antibodies, Vaccines, Cell And Gene Therapy, Other Types), By Application (Non-small Cell Lung Cancer, Prostate Cancer, Breast Cancer, Acute Myeloid Leukem...

View Report

Skin Cancer Drugs Global Market Report 2025 – By Type (Actinic Keratoses (AK), Basal cell carcinoma (BCC), Squamous cell carcinoma (SCC), Melanoma), By Drug Class (Chemotherapy, Immunotherapy, Targeted Agents & Other Dru...

View Report

Pancreatic Cancer Drugs Global Market Report 2025 – By Type (Pancreatic Neuroendocrine Cancer Drugs, Pancreatic Exocrine Cancer Drugs), By Drug Combination (Single, Double, Triplet, Quadruplet), By End User (Hospital Pha...

View Report

Lung Cancer Drugs Global Market Report 2025 – By Drugs (Gemzar, Paraplatin, Taxotere, Navelbine, Avastin, Tarceva, Iressa, Other Drugs), By Disease Type (Small cell lung cancer (SCLC), Non-small cell lung cancer (NSCLC))...

View Report

Frequently Asked Questions

What is the definition of the Cancer Biomarker market?

How will the Cancer Biomarker market drivers and restraints affect the market dynamics? What forces will shape the Cancer Biomarker industry going forward?

The market major growth driver - The Surging Incidence Of Cancer Fueling Growth In The Cancer Biomarker Market. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Cancer Biomarker market?

The cancer biomarker market size has grown rapidly in recent years. It will grow from $22.19 billion in 2024 to $25.09 billion in 2025 at a compound annual growth rate (CAGR) of 13.1%. The growth in the historic period can be attributed to shift to personalized medicine, immunotherapy innovations, regulatory framework evolution, collaborative research efforts, focus on non-coding RNAs. The cancer biomarker market size is expected to see rapid growth in the next few years. It will grow to $45.33 billion in 2029 at a compound annual growth rate (CAGR) of 15.9%. The growth in the forecast period can be attributed to shift to patient-centric diagnostics, integration of biomarkers in clinical trials, emergence of multiplex biomarker panels, exploration of non-coding RNAs, commercialization of biomarker tests. Major trends in the forecast period include advancements in genomics, precision medicine approaches, liquid biopsies, immunotherapy advancements, artificial intelligence (ai) integration. For further insights on this market, request a sample here

How is the Cancer Biomarker market segmented?

The cancer biomarkermarket covered in this report is segmented –
1) By Biomarkers Type: Protein Biomarkers, Genetic Biomarkers, Other Cancer Biomarkers
2) By Profiling Technologies: Omics Technologies, Imaging Technologies, Immunoassay, Bioinformatics, Cytogenetics
3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Thyroid Cancer, Kidney Cancer, Other Cancers
4) By Application: Diagnostics, Research And Development, Prognostics, Risk Assessment, Other Applications Subsegments:
1) By Protein Biomarkers: Tumor-Specific Antigens, Circulating Tumor Protein
2) By Genetic Biomarkers: DNA Mutations, RNA Expression Profiles
3) By Other Cancer Biomarkers: Epigenetic Biomarkers, Metabolomic Biomarkers For further insights on this market, request a sample here

Which region has the largest share of the Cancer Biomarker market? What are the other regions covered in the report?

North America was the largest region in the cancer biomaker market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer biomarker market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Cancer Biomarker market?

What are the key trends in the Cancer Biomarker market?

Major trends in this market include Advancements In AI-Powered Cancer Biomarkers: Enhancing Diagnosis And Treatment Precision. For further insights on this market, request a sample here.

Book your 30 minutes free consultation with our research experts

Cancer Biomarker Global Market Report 2025

Cancer Biomarker Market Overview

What Is Covered Under Cancer Biomarker Market?

What Is The Cancer Biomarker Market Size 2025 And Growth Rate?

What Is The Cancer Biomarker Market Growth Forecast?

What’s The Trade War Impact On Medical Equipment Industry?

How Is The Cancer Biomarker Market Segmented?

What Is Driving The Cancer Biomarker Market? The Surging Incidence Of Cancer Fueling Growth In The Cancer Biomarker Market

What Is Driving The Cancer Biomarker Market? Growing Geriatric Population Fuels Cancer Biomarker Market Expansion

Who Are The Major Players In The Global Cancer Biomarker Market?

What Are The Key Trends Of The Global Cancer Biomarker Market? Advancements In AI-Powered Cancer Biomarkers: Enhancing Diagnosis And Treatment Precision

What Are The Key Trends Of The Global Cancer Biomarker Market? Pioneering Advancements In Cancer Biomarkers Market

Cancer Biomarker Market Merger And Acquisition: Biocare Medical Acquires Empire Genomics To Enhance Cancer Diagnostics Capabilities

Regional Outlook For The Global Cancer Biomarker Market

What Defines the Cancer Biomarker Market?

How is Market Value Defined and Measured?

What is the Market Assessment and Strategic Outlook for the Cancer Biomarker Industry?

Cancer Biomarker Market Report Forecast Analysis

Table Of Contents

List Of Tables

List Of Figures

Frequently Asked Questions